DIEBOLD NIXDORF INC

DBD refers to the common stock of Diebold Nixdorf, Incorporated, a company that provides banking and retail technology solutions. The ticker trades on the New York Stock Exchange. The company focuses on self-service systems, software, and services for financial institutions and retailers worldwide. DBD stock represents an ownership stake in that business. For the latest price and trading details, see the DBD quote displayed on this page.

DBD operates in the banking and retail technology space, competing with companies that provide ATMs, self-service kiosks, point-of-sale systems, and related software. Competitors include NCR Atleos, Hyosung, and Glory, among others. Because the industry is global, DBD faces competition from both large multinationals and regional providers. Competitive positioning, product innovation, and service quality are key factors to monitor when researching DBD.

DBD's recent performance depends on current market conditions, company-specific news, and broader sector trends. Rather than relying on stale data, check the latest price, percentage change, and trading volume shown on this page. Those figures reflect real-time or delayed market activity. For a fuller picture, compare the current quote with the 52-week range and recent price history also available here.

The current price of DBD changes continuously during market hours and may also move in pre-market or after-hours trading. The most accurate figure is the live quote displayed on this page, which includes the latest price, change, and volume. Avoid relying on delayed or static numbers from other sources, as they may no longer reflect the current market. Use the page's quote as your primary reference.

Valuation for DBD can be assessed using metrics such as the price-to-earnings ratio, price-to-sales ratio, enterprise value multiples, and free cash flow yield. Because DBD operates in a capital-intensive technology services industry, comparing these metrics with peers and with DBD's own historical averages can add context. The latest ratios and financial data are available on this page, where you can review current valuation figures.

DBD faces risks related to its industry, including intense competition, rapid technological change, and dependence on banking and retail capital spending. Operational execution, supply chain disruptions, and global economic conditions can also affect results. Additionally, the company has historically carried significant debt, which can amplify financial risk. Reviewing DBD's latest financial statements and risk disclosures provides a more complete picture of these and other potential risks.